FRANKLIN RESOURCES INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$2,831,401
+30.8%
183,025
+32.8%
0.00%0.0%
Q2 2023$2,164,538
+672.7%
137,781
+710.5%
0.00%
Q1 2023$280,144
+35.5%
16,999
+28.3%
0.00%
Q4 2022$206,762
+16.8%
13,254
-2.8%
0.00%
Q3 2022$177,000
+24.6%
13,629
+35.5%
0.00%
Q2 2022$142,000
-74.4%
10,057
-74.0%
0.00%
Q1 2022$554,000
-1.9%
38,716
-6.6%
0.00%
Q4 2021$565,000
-59.1%
41,456
-50.9%
0.00%
-100.0%
Q3 2021$1,383,000
-68.3%
84,437
-67.4%
0.00%
-50.0%
Q2 2021$4,358,000
-36.4%
258,962
-31.0%
0.00%
-33.3%
Q1 2021$6,857,000
+16.8%
375,534
+16.4%
0.00%
+50.0%
Q4 2020$5,873,000
-10.3%
322,697
-12.0%
0.00%
-33.3%
Q3 2020$6,546,000
-11.5%
366,895
-13.5%
0.00%
-25.0%
Q2 2020$7,398,000
+1.0%
424,150
-12.1%
0.00%
-20.0%
Q1 2020$7,322,000
-12.1%
482,357
+14.3%
0.01%
+25.0%
Q4 2019$8,331,000
-17.0%
422,181
-27.9%
0.00%
-20.0%
Q3 2019$10,034,000
-6.6%
585,378
-3.5%
0.01%
-16.7%
Q2 2019$10,740,000
+17.8%
606,830
+35.6%
0.01%
+20.0%
Q1 2019$9,116,000447,5130.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders